House Passes FDA Funding Bill As Part Of Fiscal 2021 Minibus

By Beth Wang / July 24, 2020 at 4:14 PM
The House on Friday (July 24) passed 224-189 an FDA spending package that would give the agency $3.21 billion in discretionary funding, an increase of $40.8 million over fiscal 2020 funding levels, and would provide the agency authority to recall drugs. The bill passed as part of a minibus appropriations package (H.R. 7608), with three amendments calling for FDA to allocate appropriated funds to specific agency programs. Senate appropriators have yet to introduce their bill. Inside Health Policy previously...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.